{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:13:10Z","timestamp":1769314390356,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK099090"],"award-info":[{"award-number":["DK099090"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.mce.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T12:53:55Z","timestamp":1467636835000},"page":"176-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Receptor antagonism\/agonism can be uncoupled from pharmacoperone activity"],"prefix":"10.1016","volume":"434","author":[{"given":"Jo Ann","family":"Janovick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy P.","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emery","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Kenakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Scampavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3724-8128","authenticated-orcid":false,"given":"P. Michael","family":"Conn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.mce.2016.07.003_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-2999(97)01021-2","article-title":"Properties of a new radioiodinated antagonist for human vasopressin V2 and V1a receptors","volume":"331","author":"Ala","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.mce.2016.07.003_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acs.jcim.5b00705","article-title":"Interplay between two allosteric sites and their influence on agonist binding in human mu opioid receptor","volume":"56","author":"Bartuzi","year":"2016","journal-title":"J.\u00a0Chem. Inf. Model"},{"issue":"3","key":"10.1016\/j.mce.2016.07.003_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.beem.2013.03.003","article-title":"The calcium sensing receptor life cycle: trafficking, cell surface expression, and degradation","volume":"27","author":"Breitwieser","year":"2013","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.07.003_bib4","first-page":"30","article-title":"Pharmacoperones and the calcium sensing receptor: exogenous and endogenous regulators","volume":"83","author":"Breitwieser","year":"2014","journal-title":"Pharmacol. Res. Off. J. Ital. Pharmacol. Soc."},{"issue":"6","key":"10.1016\/j.mce.2016.07.003_bib5","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/j.1476-5381.2011.01403.x","article-title":"Behind the curtain: cellular mechanisms for allosteric modulation of calcium-sensing receptors","volume":"165","author":"Cavanaugh","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.mce.2016.07.003_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1471-4159.2003.02040.x","article-title":"The first and third intracellular loops together with the carboxy terminal tail of the delta-opioid receptor contribute toward functional interaction with Galpha16","volume":"87","author":"Chan","year":"2003","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.mce.2016.07.003_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-5793(91)80167-2","article-title":"Specific activation of Gs by synthetic peptides corresponding to an intracellular loop of the beta-adrenergic receptor","volume":"279","author":"Cheung","year":"1991","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.mce.2016.07.003_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","article-title":"Allosteric binding sites on cell-surface receptors: novel targets for drug discovery","volume":"1","author":"Christopoulos","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.mce.2016.07.003_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/pr.54.2.323","article-title":"G\u00a0protein-coupled receptor allosterism and complexing","volume":"54","author":"Christopoulos","year":"2002","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.mce.2016.07.003_bib10","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.C200629200","article-title":"Novel receptor partners and function of receptor activity-modifying proteins","volume":"278","author":"Christopoulos","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5","key":"10.1016\/j.mce.2016.07.003_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbamem.2011.02.007","article-title":"Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain","volume":"1808","author":"Ciruela","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mce.2016.07.003_bib12","first-page":"38","article-title":"Transitioning pharmacoperones to therapeutic use: in\u00a0vivo proof-of-principle and design of high throughput screens","volume":"83","author":"Conn","year":"2014","journal-title":"Pharmacol. Res. Off. J. Ital. Pharmacol. Soc."},{"issue":"8","key":"10.1016\/j.mce.2016.07.003_bib13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tips.2015.05.004","article-title":"Assay strategies for identification of therapeutic leads that target protein trafficking","volume":"36","author":"Conn","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"45","key":"10.1016\/j.mce.2016.07.003_bib14","doi-asserted-by":"crossref","first-page":"29462","DOI":"10.1074\/jbc.273.45.29462","article-title":"Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor","volume":"273","author":"Cotte","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"issue":"4","key":"10.1016\/j.mce.2016.07.003_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nchembio.1770","article-title":"Pharmacological folding chaperones act as allosteric ligands of Frizzled4","volume":"11","author":"Generoso","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.mce.2016.07.003_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.abb.2004.01.001","article-title":"Structural and functional characterization of the first intracellular loop of human thromboxane A2 receptor","volume":"423","author":"Geng","year":"2004","journal-title":"Arch.ives Biochem. Biophys.ics"},{"key":"10.1016\/j.mce.2016.07.003_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0076-6879(87)41063-X","article-title":"Use of lithium ion in measurement of stimulated pituitary inositol phospholipid turnover","volume":"141","author":"Huckle","year":"1987","journal-title":"Methods Enzymol."},{"issue":"9","key":"10.1016\/j.mce.2016.07.003_bib18","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1073\/pnas.0914261107","article-title":"Salt bridge integrates GPCR activation with protein trafficking","volume":"107","author":"Janovick","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.mce.2016.07.003_bib19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/jpet.102.048454","article-title":"Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor","volume":"305","author":"Janovick","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"1\u20132","key":"10.1016\/j.mce.2016.07.003_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2007.04.012","article-title":"Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in\u00a0vitro","volume":"272","author":"Janovick","year":"2007","journal-title":"Mol. Cell Endocrinol."},{"issue":"1\u20132","key":"10.1016\/j.mce.2016.07.003_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2008.09.015","article-title":"Increased plasma membrane expression of human follicle-stimulating hormone receptor by a small molecule thienopyr(im)idine","volume":"298","author":"Janovick","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"issue":"6","key":"10.1016\/j.mce.2016.07.003_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0165-6147(02)02036-9","article-title":"The ligand paradox between affinity and efficacy: can you be there and not make a difference?","volume":"23","author":"Kenakin","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.mce.2016.07.003_bib23","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1093\/nar\/29.7.e39","article-title":"A\u00a0GFP-equipped bidirectional expression module well suited for monitoring tetracycline-regulated gene expression in mouse","volume":"29","author":"Krestel","year":"2001","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.mce.2016.07.003_bib24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/endo.135.1.8013367","article-title":"Stable transfection of GH3 cells with rat gonadotropin-releasing hormone receptor complementary deoxyribonucleic acid results in expression of a receptor coupled to cyclic adenosine 3\u2032,5\u2032-monophosphate-dependent prolactin release via a G-protein","volume":"135","author":"Kuphal","year":"1994","journal-title":"Endocrinology"},{"issue":"7596","key":"10.1016\/j.mce.2016.07.003_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nature17154","article-title":"The conformational signature of beta-arrestin2 predicts its trafficking and signalling functions","volume":"531","author":"Lee","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mce.2016.07.003_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/jpet.105.095554","article-title":"Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor","volume":"316","author":"Macion-Dazard","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mce.2016.07.003_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.physiol.63.1.607","article-title":"Nephrogenic diabetes insipidus","volume":"63","author":"Morello","year":"2001","journal-title":"Annu. Rev. Physiol."},{"issue":"12","key":"10.1016\/j.mce.2016.07.003_bib28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0165-6147(00)01575-3","article-title":"Pharmacological chaperones: a new twist on receptor folding","volume":"21","author":"Morello","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.mce.2016.07.003_bib29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.mce.2016.07.003_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4615-4871-3_45","article-title":"Mapping peptide antagonist binding sites of the human V1a and V2 vasopressin receptors","volume":"449","author":"Mouillac","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.mce.2016.07.003_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/1087057116653925","article-title":"Identification of potential pharmacoperones capable of rescuing the functionality of misfolded vasopressin 2 receptor involved in nephrogenic diabetes insipidus","author":"Smith","year":"2016","journal-title":"J.\u00a0Biomol. Screen"},{"issue":"1","key":"10.1016\/j.mce.2016.07.003_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.embor.7400052","article-title":"Roles of G-protein-coupled receptor dimerization","volume":"5","author":"Terrillon","year":"2004","journal-title":"EMBO Rep."},{"issue":"4","key":"10.1016\/j.mce.2016.07.003_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/me.2002-0222","article-title":"Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis","volume":"17","author":"Terrillon","year":"2003","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.mce.2016.07.003_bib34","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1073\/pnas.0305322101","article-title":"Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns","volume":"101","author":"Terrillon","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.mce.2016.07.003_bib35","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1210\/me.2009-0041","article-title":"Pharmacochaperone-mediated rescue of calcium-sensing receptor loss-of-function mutants","volume":"23","author":"White","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.mce.2016.07.003_bib36","doi-asserted-by":"crossref","first-page":"836","DOI":"10.14348\/molcells.2015.0263","article-title":"Structural studies of G protein-coupled receptors","volume":"38","author":"Zhang","year":"2015","journal-title":"Mol. Cells"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716302349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716302349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T10:33:21Z","timestamp":1572950001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720716302349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":36,"alternative-id":["S0303720716302349"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2016.07.003","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor antagonism\/agonism can be uncoupled from pharmacoperone activity","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}